{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:09:19Z","timestamp":1782302959928,"version":"3.54.5"},"reference-count":42,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jmsacl.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T23:28:00Z","timestamp":1713655680000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Quantitation of propofol metabolites by LC\u2013MS\/MS demonstrating long detection window for urine drug monitoring"],"prefix":"10.21627","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-4162","authenticated-orcid":false,"given":"Thomas G.","family":"Rosano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiley L.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"Whitely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8209-1774","authenticated-orcid":false,"given":"Nathaniel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-0223","authenticated-orcid":false,"given":"Melissa","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2024.04.001_b0005","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jmsacl.2024.04.001_b0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0378-4347(00)80092-4","article-title":"Estimation of ICI 35,868 (Diprivan R) in blood by high-performance liquid chromatography, following coupling with Gibbs' reagent","volume":"223","author":"Adam","year":"1981","journal-title":"J. Chromatogr."},{"issue":"Suppl 3","key":"10.1016\/j.jmsacl.2024.04.001_b0015","first-page":"55","article-title":"Pharmacokinetics of propofol ('Diprivan') as an induction agent","volume":"61","author":"Kay","year":"1985","journal-title":"Postgrad. Med. J."},{"issue":"10","key":"10.1016\/j.jmsacl.2024.04.001_b0020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/bja\/58.10.1075","article-title":"Disposition of propofol in patients undergoing surgery: A comparison in men and women","volume":"58","author":"Kay","year":"1986","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpba.2016.04.026","article-title":"Determination of total and unbound propofol in patients during intensive care sedation by ultrafiltration and LC-MS\/MS","volume":"126","author":"Eisenried","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.04.001_b0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0378-4347(87)80145-7","article-title":"High-performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine","volume":"417","author":"Vree","year":"1987","journal-title":"J. Chromatogr."},{"issue":"10","key":"10.1016\/j.jmsacl.2024.04.001_b0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/00498259409043299","article-title":"Use of proton NMR spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient","volume":"24","author":"Sneyd","year":"1994","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.jmsacl.2024.04.001_b0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1515\/dmpt-2017-0003","article-title":"Verification of propofol sulfate as a further human propofol metabolite using LC-ESI-QQQ-MS and LC-ESI-QTOF-MS analysis","volume":"32","author":"Maas","year":"2017","journal-title":"Drug Metab. Pers. Ther."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0045","doi-asserted-by":"crossref","unstructured":"P. Favetta 1, C. Dufresne, M. D\u00e9sage, O. Pa\u00efss\u00e9, J. P. Perdrix, R. Boulieu, J. Guitton, Detection of new propofol metabolites in human urine using gas chromatography\/mass spectrometry and liquid chromatography\/mass spectrometry techniques. Rapid Commun. Mass Spectrom. 14(20) (2000)1932-1936. 10.1002\/1097-0231(20001030)14:20<1932::AID-RCM114>3.0.CO;2-P.","DOI":"10.1002\/1097-0231(20001030)14:20<1932::AID-RCM114>3.3.CO;2-G"},{"key":"10.1016\/j.jmsacl.2024.04.001_b0050","doi-asserted-by":"crossref","unstructured":"P. Veroli 1, B. O'Kelly, F. Bertrand, J.H. Trouvin, R. Farinotti, C. Ecoffey, Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br. J. Anaesth. 68(2) (1992) 183-186. 10.1093\/bja\/68.2.183.","DOI":"10.1093\/bja\/68.2.183"},{"issue":"1","key":"10.1016\/j.jmsacl.2024.04.001_b0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/00498259209053107","article-title":"Propofol metabolism in man during the anhepatic and reperfusion phases of liver transplantation","volume":"22","author":"Gray","year":"1992","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1016\/j.jmsacl.2024.04.001_b0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00228-006-0130-2","article-title":"Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver","volume":"62","author":"Al-Jahdari","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.jmsacl.2024.04.001_b0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0006-2952(97)00534-0","article-title":"Drug glucuronidation by human renal UDP-glucuronosyltransferases","volume":"55","author":"McGurk","year":"1998","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.jmsacl.2024.04.001_b0070","first-page":"829","article-title":"In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9","volume":"69","author":"Mukai","year":"2014","journal-title":"Pharmazie"},{"issue":"1\u20132","key":"10.1016\/j.jmsacl.2024.04.001_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002280050074","article-title":"Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney","volume":"50","author":"Raoof","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.04.001_b0080","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/00000542-200010000-00020","article-title":"The role of human lungs in the biotransformation of propofol","volume":"93","author":"Dawidowicz","year":"2000","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.jmsacl.2024.04.001_b0085","first-page":"1013","article-title":"Subcellular expression of UGT1A6 and CYP1A1 responsible for propofol metabolism in human brain","volume":"22","author":"Zhang","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.jmsacl.2024.04.001_b0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2165\/00003088-198917050-00002","article-title":"Pharmacokinetic implications for the clinical use of propofol","volume":"17","author":"Kanto","year":"1989","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.04.001_b0095","first-page":"77","article-title":"Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study","volume":"44","author":"Nathan","year":"1993","journal-title":"Acta Anaesthesiol. Belg."},{"issue":"6","key":"10.1016\/j.jmsacl.2024.04.001_b0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/bja\/aen276","article-title":"Urinary propofol metabolites in early life after single intravenous bolus","volume":"101","author":"Allegaert","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.04.001_b0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/157488409788184927","article-title":"Is propofol the perfect hypnotic agent for procedural sedation in neonates?","volume":"4","author":"Allegaert","year":"2009","journal-title":"Curr. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.04.001_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13318-012-0109-6","article-title":"Urinary metabolites after intravenous propofol bolus in neonates","volume":"38","author":"Smits","year":"2013","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jmsacl.2024.04.001_b0115","first-page":"26","article-title":"Medical manslaughter","volume":"106","author":"Lyons","year":"2013","journal-title":"Ir. Med. J."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.04.001_b0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12630-022-02382-2","article-title":"Propofol misuse in medical professions: a scoping review","volume":"70","author":"Burnett","year":"2023","journal-title":"Can. J. Anaesth."},{"issue":"7","key":"10.1016\/j.jmsacl.2024.04.001_b0125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/j.1875-9114.2011.01089.x","article-title":"Drug testing in the workplace","volume":"32","author":"Phan","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmsacl.2024.04.001_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.110070","article-title":"Development of a LC-MS\/MS method for determination of propofol-glucuronide in hair and preliminary study on relationships between dose and hair concentration","volume":"306","author":"Kwon","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpba.2017.08.035","article-title":"Simultaneous extraction of propofol and propofol glucuronide from hair followed by validated LC-MS\/MS analyses","volume":"146","author":"Maas","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"21","key":"10.1016\/j.jmsacl.2024.04.001_b0140","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1007\/s00216-013-7105-9","article-title":"Quantitative analysis of propofol-glucuronide in hair as a marker for propofol abuse","volume":"405","author":"Kim","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpba.2013.06.027","article-title":"Rapid and sensitive determination of propofol glucuronide in hair by liquid chromatography and tandem mass spectrometry","volume":"85","author":"Kim","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2016.01.061","article-title":"Determination of propofol glucuronide from hair sample by using mixed mode anion exchange cartridge and liquid chromatography tandem mass spectrometry","volume":"1015\u20131016","author":"Kwak","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.jmsacl.2024.04.001_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PAF.0000000000000209","article-title":"Postmortem propofol levels: A case of residual detection long after administration","volume":"37","author":"George","year":"2016","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0160","doi-asserted-by":"crossref","unstructured":"C. Bleeker, T. Vree, A. Lagerwerf, E. Willems-van Bree, Recovery and long-term renal excretion of propofol, its glucuronide, and two di-isopropylquinol glucuronides after propofol infusion during surgery. Br. J. Anaesth. 101(2) (2008) 207-212. 10.1093\/bja\/aen134.","DOI":"10.1093\/bja\/aen134"},{"key":"10.1016\/j.jmsacl.2024.04.001_b0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4236\/pp.2013.47076","article-title":"Long-term detection of propofol glucuronide in urine following anesthesia induction and maintenance with propofol","volume":"4","author":"Salerno","year":"2013","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0170","unstructured":"ANSI\/ASB Standard 036. (2019) Standard practices for method validation in forensic toxicology \u2013 first edition. https:\/\/aafs.org\/sites\/default\/files\/media\/documents\/036_Std_e1.pdf (accessed Jul 7, 2023)."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0175","unstructured":"Clinical Laboratory Standards. New York State Department of Health. https:\/\/www.wadsworth.org\/regulatory\/clep\/clinical-labs\/laboratory-standards (Accessed 01\/07\/2024)."},{"key":"10.1016\/j.jmsacl.2024.04.001_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462360","article-title":"Fluoride-assisted liquid chromatography-tandem mass spectrometry method for simultaneous analysis of propofol and its metabolites without derivatization in urine","volume":"1652","author":"Lee","year":"2021","journal-title":"J. Chromatogr. A"},{"issue":"4","key":"10.1016\/j.jmsacl.2024.04.001_b0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/00498258809041679","article-title":"Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol","volume":"18","author":"Simons","year":"1988","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.jmsacl.2024.04.001_b0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/bja\/88.5.653","article-title":"Propofol metabolites in man following propofol induction and maintenance","volume":"88","author":"Favetta","year":"2002","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.04.001_b0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bja\/68.3.311","article-title":"Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro","volume":"68","author":"Janicki","year":"1992","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.04.001_b0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1213\/00000539-199304000-00024","article-title":"Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes","volume":"76","author":"Baker","year":"1993","journal-title":"Anesth. Analg."},{"issue":"5","key":"10.1016\/j.jmsacl.2024.04.001_b0205","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/bja\/74.5.558","article-title":"Human cytochrome P450 mono-oxygenase system is suppressed by propofol","volume":"74","author":"Chen","year":"1995","journal-title":"Br. J. Anaesth."},{"issue":"7","key":"10.1016\/j.jmsacl.2024.04.001_b0210","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF03019002","article-title":"Propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters","volume":"47","author":"Chen","year":"2000","journal-title":"Can. J. Anaesth."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:47Z","timestamp":1767770567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X24000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":42,"alternative-id":["S2667145X24000191"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.04.001","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitation of propofol metabolites by LC\u2013MS\/MS demonstrating long detection window for urine drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}